Skip to main content

The latest news &
insights from ArteraAI

View company news, research articles, publications, and industry thought leadership currently making headlines in the cancer treatment space.

Show All
Press & Media
Publications & Presentations
Upcoming & Past Events
Videos
Insights
Press & Media

VIDEO: ‘Practice-changing’ AI-derived biomarker can tailor ADT in high-risk...

In this Healio video exclusive, Andrew Armstrong, MD, discusses his presentation from the Genitourinary Cancer session at the [...]

Press & Media

Dr. Spratt on the urologist’s role in helping to...

A recent survey revealed that about 1 in 4 men wouldn’t want to know that they had cancer. In this video, Daniel E. Spratt, M [...]

Press & Media

AI Can Help Boost Confidence In Cancer Care Among...

Cancer care is a multifaceted and ever-evolving space. And, while the ongoing evolution and new technologies in cancer care a [...]

Press & Media

Dr. Rana McKay on the benefits of the ArteraAI...

In this video, Rana R. McKay, MD, discusses the benefits of ArteraAI in prostate cancer. McKay is a medical oncologist and as [...]

Press & Media

Balancing Innovation and the Ethical Adoption of AI in...

In recent years, the rapid advancement of artificial intelligence (AI) has created a wave of excitement and anticipation with [...]

Press & Media

Unlocking the power of health care AI tools through...

Artificial intelligence (AI) has emerged as a game-changing technology with the potential to revolutionize health care. Speci [...]

Press & Media

AI-Derived Model Identifies Prostate Cancer Patients Likely to Benefit...

An artificial intelligence (AI)-derived model can identify prostate cancer patients who are likely to benefit from short-term [...]

Press & Media

AI May Predict Benefit with Hormone Therapy Plus Radiotherapy...

Artificial intelligence (AI) may predict which patients with intermediate-risk prostate cancer will benefit from short-term a [...]

Press & Media

Novel AI Model Predicts ADT Benefit in Patients With...

Results of a phase 3 randomized trial published in NEJM Evidence suggest a novel artificial intelligence (AI) model may help [...]

Load More